102
Participants
Start Date
February 1, 2021
Primary Completion Date
March 31, 2021
Study Completion Date
June 9, 2021
Vitamin D 25 (OH) 12000 IU in the form of a sublingual sprayable microemulsion
This is a prospective, randomized, double blind, and controlled clinical study to investigate the impact of the high dose vitamin D supplementation on laboratory markers of systemic inflammation such as CRP, ferritin and IL-6 in hospitalized patients with COVID-19. Patients included in the study will be randomized into two groups and receive a placebo (as a control group) or cholecalciferol administered sublingually for 5 day
Pauls Stradins Clinical Univeristy Hospital, Riga
Pauls Stradins Clinical University Hospital
OTHER